These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7829701)

  • 21. Acute lipodermatosclerosis is associated with venous insufficiency.
    Greenberg AS; Hasan A; Montalvo BM; Falabella A; Falanga V
    J Am Acad Dermatol; 1996 Oct; 35(4):566-8. PubMed ID: 8859285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration.
    Burnand KG; Whimster I; Naidoo A; Browse NL
    Br Med J (Clin Res Ed); 1982 Oct; 285(6348):1071-2. PubMed ID: 6812751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiogenesis in lipodermatosclerosis: implication for venous ulcer formation.
    Herouy Y; Kreis S; Mueller T; Duerk T; Martiny-Baron G; Reusch P; May F; Idzko M; Norgauer Y
    Int J Mol Med; 2009 Nov; 24(5):645-51. PubMed ID: 19787198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxygenation of the dermis and subcutis in dermatoliposclerosis].
    Roszinski S; Köser T; Wilhelm KP; Schmeller W
    Vasa; 1993; 22(4):297-305. PubMed ID: 8310768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of durometry in assessment of venous disease.
    Choh CT; Wall ML; Brown MD; Nicolson AM; Simms MH
    Phlebology; 2010 Apr; 25(2):94-9. PubMed ID: 20348456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical removal of ulcer and lipodermatosclerosis followed by split-skin grafting (shave therapy) yields good long-term results in "non-healing" venous leg ulcers.
    Schmeller W; Gaber Y
    Acta Derm Venereol; 2000; 80(4):267-71. PubMed ID: 11028859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for chronic ulceration in patients with varicose veins: a case control study.
    Robertson L; Lee AJ; Gallagher K; Carmichael SJ; Evans CJ; McKinstry BH; Fraser SC; Allan PL; Weller D; Ruckley CV; Fowkes FG
    J Vasc Surg; 2009 Jun; 49(6):1490-8. PubMed ID: 19497512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciitis.
    Naschitz JE; Yeshurun D; Schwartz H; Croitoru S; Shajrawi I; Misselevich I; Boss JH
    Cardiovasc Surg; 1993 Oct; 1(5):524-9. PubMed ID: 8076090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
    Ghosh S; Baker L; Chen F; Khera Z; Vain A; Zhang K; Hood A; Smith H; Chen H; Jagasia M; Tkaczyk E
    Arch Dermatol Res; 2023 Nov; 315(9):2545-2554. PubMed ID: 37227518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abundance of plasma cells in a case of lipodermatosclerosis.
    Fernandez-Flores A; Manjón JA
    Acta Dermatovenerol Croat; 2010; 18(1):27-31. PubMed ID: 20361885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease.
    Margolis DJ; Kruithof EK; Barnard M; Howe K; Lazarus GS
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):204-8. PubMed ID: 8642083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin involvement in systemic sclerosis.
    Czirják L; Foeldvari I; Müller-Ladner U
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v44-5. PubMed ID: 18784142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of dermal edema in lipodermatosclerosis, lymphedema, and cardiac insufficiency. High-frequency ultrasound examination of intradermal echogenicity.
    Gniadecka M
    J Am Acad Dermatol; 1996 Jul; 35(1):37-41. PubMed ID: 8682961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducible measurements to quantify cutaneous involvement in scleroderma.
    Aghassi D; Monoson T; Braverman I
    Arch Dermatol; 1995 Oct; 131(10):1160-6. PubMed ID: 7574833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipodermatosclerosis: successful treatment with danazol.
    Hafner C; Wimmershoff M; Landthaler M; Vogt T
    Acta Derm Venereol; 2005; 85(4):365-6. PubMed ID: 16191868
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of radical surgery in the management of CEAP C5/6 and lipodermatosclerosis.
    Martis G; Laczik R
    Phlebology; 2016 Dec; 31(10):753-768. PubMed ID: 27257053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of urokinase-type and tissue-type plasminogen activator occurs at an early stage of progressing stages of chronic venous insufficiency.
    Peschen M; Rogers AA; Chen WY; Vanscheidt W
    Acta Derm Venereol; 2000 May; 80(3):162-6. PubMed ID: 10954203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Removal of dermal edema with class I and II compression stockings in patients with lipodermatosclerosis.
    Gniadecka M; Karlsmark T; Bertram A
    J Am Acad Dermatol; 1998 Dec; 39(6):966-70. PubMed ID: 9843010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermal oedema in lipodermatosclerosis: distribution, effects of posture and compressive theraphy evaluated by high-frequency ultrasonography.
    Gniadecka M
    Acta Derm Venereol; 1995 Mar; 75(2):120-4. PubMed ID: 7604639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.